cas 869365-97-9|| where to buy (5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone

Название продукции:(5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone

IUPAC Name:(5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone

: CAS：869365-97-9; Молекулярная формула：C13H6ClF2IO; Чистота：98%

Упаковочная единица	Доступно для заказа	Цена ($)
CM128905-100mg	in stock	ſƱ
CM128905-250mg	in stock	ƱƱƋ
CM128905-1g	in stock	ǕǲƱ
CM128905-5g	in stock	ɐſȌ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 869365-97-9 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:869365-97-9; Молекулярная формула:C13H6ClF2IO; Точка плавления:-; Smiles-код:FC1=CC=CC(F)=C1C(=O)C1=C(I)C=CC(Cl)=C1; Плотность:

: Номер в каталоге:CM128905; Молекулярная масса:378.54; Точка кипения:433°C at 760 mmHg; Номер Mdl:MFCD10565698; Хранение:Keep in dark place, store at 2-8°C.

: Alisertib; Puma Biotechnology announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial of alisertib monotherapy for the treatment of patients with extensive stage small cell lung cancer. The ALISCA-Lung1 trial will enroll up to 60 patients with extensive stage small cell lung cancer who have progressed on or after first-line platinum-based chemotherapy and immunotherapy. The primary endpoint of the trial is objective response rate, with secondary endpoints of duration of response, disease control rate, progression-free survival and overall survival. Based upon the outcomes of the study, Puma anticipates meeting with the FDA to explore the potential for an accelerated approval pathway for alisertib in small cell lung cancer. Alisertib is an orally active and selective Aurora A kinase inhibitor, which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.